Design and characterization of calcium phosphate ceramic scaffolds for bone tissue engineering

Fernandez-Yague, 2015, Biomimetic approaches in bone tissue engineering: integrating biological and physicomechanical strategies, Adv Drug Deliv Rev, 84, 1, 10.1016/j.addr.2014.09.005 Finkemeier, 2002, Bone-grafting and bone-graft substitutes, J Bone Joint Surg Am Vol, 84A, 454, 10.2106/00004623-200203000-00020 Dorozhkin, 2010, Bioceramics of calcium orthophosphates, Biomaterials, 31, 1465, 10.1016/j.biomaterials.2009.11.050 Samavedi, 2013, Calcium phosphate ceramics in bone tissue engineering: a review of properties and their influence on cell behavior, Acta Biomater, 9, 8037, 10.1016/j.actbio.2013.06.014 Vallet-Regi, 2011, Bioceramics: from bone regeneration to cancer nanomedicine, Adv Mater, 23, 5177, 10.1002/adma.201101586 Rezwan, 2006, Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering, Biomaterials, 27, 3413, 10.1016/j.biomaterials.2006.01.039 Porter, 2009, Bone tissue engineering: a review in bone biomimetics and drug delivery strategies, Biotechnol Prog, 25, 1539 Rey, 2009, Bone mineral: update on chemical composition and structure, Osteoporosis Int, 20, 1013, 10.1007/s00198-009-0860-y Vallet-Regi, 2001, Ceramics for medical applications, J Chem Soc-Dalton Trans, 97, 10.1039/b007852m LeGeros, 2002, Bioceramics: calcium phosphate ceramics: past, present and future LeGeros, 1993, Biodegradation and bioresorption of calcium phosphate ceramics, Clin Mater, 14, 65, 10.1016/0267-6605(93)90049-D LeGeros, 2002, Properties of osteoconductive biomaterials: calcium phosphates, Clin Orthop, 395, 81, 10.1097/00003086-200202000-00009 LeGeros, 1993, Dense hydroxyapatite, 139 Dorozhkin, 2013, Calcium orthophosphate-based bioceramics, Materials, 6, 3840, 10.3390/ma6093840 Khan, 2014, Bioactive behavior of silicon substituted calcium phosphate based bioceramics for bone regeneration, Mater Sci Eng C-Mater Biol Appl, 35, 245, 10.1016/j.msec.2013.11.013 Calori, 2011, The use of bone-graft substitutes in large bone defects: any specific needs?, Injury—Int J Care Inj, 42, S56, 10.1016/j.injury.2011.06.011 Albrektsson, 2001, Osteoinduction, osteoconduction and osseointegration, Eur Spine J, 10, S96, 10.1007/s005860100282 Minardi, 2015, Evaluation of the osteoinductive potential of a bio-inspired scaffold mimicking the osteogenic niche for bone augmentation, Biomaterials, 62, 128, 10.1016/j.biomaterials.2015.05.011 Wang, 2014, Ectopic osteoid and bone formation by three calcium-phosphate ceramics in rats, rabbits and dogs, PLoS One, 9, e107044, 10.1371/journal.pone.0107044 Daculsi, 2014, The essential role of calcium phosphate bioceramics in bone regeneration, 71 Bose, 2013, Understanding of dopant-induced osteogenesis and angiogenesis in calcium phosphate ceramics, Trends Biotechnol, 31, 594, 10.1016/j.tibtech.2013.06.005 Landi, 2008, Biomimetic Mg-substituted hydroxyapatite: from synthesis to in vivo behaviour, J Mater Sci Mater Med, 19, 239, 10.1007/s10856-006-0032-y Maier, 2004, High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro, Biochim Biophys Acta—Mol Basis Dis, 1689, 6, 10.1016/j.bbadis.2004.02.004 Marie, 2001, Mechanisms of action and therapeutic potential of strontium in bone, Calcified Tissue Int, 69, 121, 10.1007/s002230010055 Marquis, 2007, Long-term beneficial effects of strontium ranelate on the quality of life in patients with vertebral osteoporosis (Soti study), Calcified Tissue Int, 80, S137 Ortolani, 2006, Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages, Bone, 38, 19, 10.1016/j.bone.2005.10.030 Pors Nielsen, 2004, The biological role of strontium, Bone, 35, 583, 10.1016/j.bone.2004.04.026 Li, 2013, Bioactive silicate materials stimulate angiogenesis in fibroblast and endothelial cell co-culture system through paracrine effect, Acta Biomater, 9, 6981, 10.1016/j.actbio.2013.02.014 Pietak, 2007, Silicon substitution in the calcium phosphate bioceramics, Biomaterials, 28, 4023, 10.1016/j.biomaterials.2007.05.003 Bose, 2011, Understanding in vivo response and mechanical property variation in MgO, SrO and SiO2 doped beta-TCP, Bone, 48, 1282, 10.1016/j.bone.2011.03.685 Carrodeguas, 2011, alpha-Tricalcium phosphate: synthesis, properties and biomedical applications, Acta Biomater, 7, 3536, 10.1016/j.actbio.2011.06.019 Gibson, 2002, Effect of silicon substitution on the sintering and microstructure of hydroxyapatite, J Am Ceram Soc, 85, 2771, 10.1111/j.1151-2916.2002.tb00527.x Farzadi, 2014, Magnesium incorporated hydroxyapatite: synthesis and structural properties characterization, Ceram Int, 40, 6021, 10.1016/j.ceramint.2013.11.051 Landi, 2000, Densification behaviour and mechanisms of synthetic hydroxyapatites, J Eur Ceram Soc, 20, 2377, 10.1016/S0955-2219(00)00154-0 Bigi, 2007, Strontium-substituted hydroxyapatite nanocrystals, Inorg Chim Acta, 360, 1009, 10.1016/j.ica.2006.07.074 Bigi, 1998, Structural refinements of strontium substituted hydroxylapatites, Mater Sci Forum, 814, 10.4028/www.scientific.net/MSF.278-281.814 Landi, 2008, Development of Sr and CO3 co-substituted hydroxyapatites for biomedical applications, Acta Biomater, 4, 656, 10.1016/j.actbio.2007.10.010 Landi, 2007, Sr-substituted hydroxyapatites for osteoporotic bone replacement, Acta Biomater, 3, 961, 10.1016/j.actbio.2007.05.006 Supova, 2015, Substituted hydroxyapatites for biomedical applications: a review, Ceram Int, 41, 9203, 10.1016/j.ceramint.2015.03.316 Scheffler, 2005 Schwartzwalder K, Somers AV, inventors. General Motors Corporation, assignee. Method of making porous ceramic articles. US patent 3,090,094. 1963 May 21. Chang, 2000, Osteoconduction at porous hydroxyapatite with various pore configurations, Biomaterials, 21, 1291, 10.1016/S0142-9612(00)00030-2 Saiz, 2007, Preparation of porous hydroxyapatite scaffolds, Mater Sci Eng C-Biomim Supramol Syst, 27, 546, 10.1016/j.msec.2006.05.038 Tian, 2001, Preparation of porous hydroxyapatite, J Mater Sci, 36, 3061, 10.1023/A:1017935411108 Padilla, 2007, Bioactive glass as precursor of designed-architecture scaffolds for tissue engineering, J Biomed Mater Res Part A, 81A, 224, 10.1002/jbm.a.30934 Santos, 1994, Microstructural characterization of glass-reinforced hydroxyapatite composites, Biomaterials, 15, 5, 10.1016/0142-9612(94)90188-0 Colombo, 2002, Ceramic foams from preceramic polymers, Mater Res Innov, 6, 260, 10.1007/s10019-002-0209-z Shepherd, 2011, Calcium phosphate scaffolds for bone repair, JOM, 63, 83, 10.1007/s11837-011-0063-9 Lewis, 2005, Three-dimensional periodic structures, Cell Ceram Struct Manuf Properties Appl, 87 Lewis, 2006, Direct ink writing of three-dimensional ceramic structures, J Am Ceram Soc, 89, 3599, 10.1111/j.1551-2916.2006.01382.x Simon, 2007, In vivo bone response to 3D periodic hydroxyapatite scaffolds assembled by direct ink writing, J Biomed Mater Res Part A, 83A, 747, 10.1002/jbm.a.31329 Hutmacher, 2000, Scaffolds in tissue engineering bone and cartilage, Biomaterials, 21, 2529, 10.1016/S0142-9612(00)00121-6 Descamps, 2008, Manufacture of macroporous beta-tricalcium phosphate bioceramics, J Eur Ceram Soc, 28, 149, 10.1016/j.jeurceramsoc.2007.05.025 Descamps, 2008, Synthesis of macroporous beta-tricalcium phosphate with controlled porous architectural, Ceram Int, 34, 1131, 10.1016/j.ceramint.2007.01.004 Michna, 2005, Concentrated hydroxyapatite inks for direct-write assembly of 3-D periodic scaffolds, Biomaterials, 26, 5632, 10.1016/j.biomaterials.2005.02.040 Denry, 2014, Low temperature sintering of fluorapatite glass-ceramics, Dental Mater, 30, 112, 10.1016/j.dental.2013.10.009 Fu, 2011, Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives, Mater Sci Eng C—Mater Biol Appl, 31, 1245, 10.1016/j.msec.2011.04.022 Barrere, 2008, Advanced biomaterials for skeletal tissue regeneration: Instructive and smart functions, Mater Sci Eng R-Rep, 59, 38, 10.1016/j.mser.2007.12.001 Barrere, 2006, Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics, Int J Nanomed, 1, 317 Davies, 2007, Bone bonding at natural and biomaterial surfaces, Biomaterials, 28, 5058, 10.1016/j.biomaterials.2007.07.049 Davies, 2005, Understanding peri-implant endosseous healing, J Dent Educ, 67, 932, 10.1002/j.0022-0337.2003.67.8.tb03681.x Woodard, 2007, The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity, Biomaterials, 28, 45, 10.1016/j.biomaterials.2006.08.021 Diaz-Rodriguez, 2014, Key parameters in blood-surface interactions of 3D bioinspired ceramic materials, Mater Sci Eng C-Mater Biol Appl, 41, 232, 10.1016/j.msec.2014.04.058 Seyfert, 2002, In vitro hemocompatibility testing of biomaterials according to the ISO 10993-4, Biomol Eng, 19, 91, 10.1016/S1389-0344(02)00015-1 ISO, 2002 LeGeros, 2002, Properties of osteoconductive biomaterials: calcium phosphates, Clin Orthop Relat Res, 395, 81, 10.1097/00003086-200202000-00009 Autefage, 2009, Adsorption and release of BMP-2 on nanocrystalline apatite-coated and uncoated hydroxyapatite/beta-tricalcium phosphate porous ceramics, J Biomed Mater Res B Appl Biomater, 91, 706, 10.1002/jbm.b.31447 Liu, 2005, BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model, Bone, 36, 745, 10.1016/j.bone.2005.02.005 Roldan, 2010, Bone formation and degradation of a highly porous biphasic calcium phosphate ceramic in presence of BMP-7, VEGF and mesenchymal stem cells in an ectopic mouse model, J Craniomaxillofac Surg, 38, 423, 10.1016/j.jcms.2010.01.003 Guicheux, 1998, Human growth hormone locally released in bone sites by calcium-phosphate biomaterial stimulates ceramic bone substitution without systemic effects: a rabbit study, J Bone Miner Res, 13, 739, 10.1359/jbmr.1998.13.4.739 Nevins, 2005, Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial, J Periodontol, 76, 2205, 10.1902/jop.2005.76.12.2205 Irokawa, 2010, Effect of beta tricalcium phosphate particle size on recombinant human platelet-derived growth factor-BB-induced regeneration of periodontal tissue in dog, Dent Mater J, 29, 721, 10.4012/dmj.2010-033 Steffen, 2001, Porous tricalcium phosphate and transforming growth factor used for anterior spine surgery, Eur Spine J, 10, S132, 10.1007/s005860100325 Jeong, 2010, FGF2-adsorbed macroporous hydroxyapatite bone granules stimulate in vitro osteoblastic gene expression and differentiation, J Mater Sci Mater Med, 21, 1335, 10.1007/s10856-009-3971-2 Paderni, 2009, Major bone defect treatment with an osteoconductive bone substitute, Chir Organi Mov, 93, 89 Wernike, 2010, VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo, Eur Cell Mater, 19, 30, 10.22203/eCM.v019a04 Carragee, 2011, A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned, Spine J, 11, 471, 10.1016/j.spinee.2011.04.023 Choy, 2014, Incorporation of RANKL promotes osteoclast formation and osteoclast activity on beta-TCP ceramics, Bone, 69, 80, 10.1016/j.bone.2014.09.013 Polak, 2011, Analysis of the roles of microporosity and BMP-2 on multiple measures of bone regeneration and healing in calcium phosphate scaffolds, Acta Biomater, 7, 1760, 10.1016/j.actbio.2010.12.030 Wen, 2015, Comparison of bone morphogenetic protein-2 delivery systems to induce supracrestal bone guided by titanium implants in the rabbit mandible, Clin Oral Implants Res Seeley, 2007, Influence of TiO2 and Ag2O addition on tricalcium phosphate ceramics, J Biomed Mater Res A, 82, 113, 10.1002/jbm.a.31077 Chen, 2008, Anti-bacterial and cytotoxic properties of plasma sprayed silver-containing HA coatings, J Mater Sci Mater Med, 19, 3603, 10.1007/s10856-008-3529-8 Stigter, 2004, Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy, J Control Release, 99, 127, 10.1016/j.jconrel.2004.06.011 Kim, 2004, Hydroxyapatite/poly(epsilon-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery, Biomaterials, 25, 1279, 10.1016/j.biomaterials.2003.07.003 Brooks, 2014, Molded polymer-coated composite bone void filler improves tobramycin controlled release kinetics, J Biomed Mater Res B Appl Biomater, 102, 1074, 10.1002/jbm.b.33089 Surmenev, 2014, Significance of calcium phosphate coatings for the enhancement of new bone osteogenesis—a review, Acta Biomater, 10, 557, 10.1016/j.actbio.2013.10.036 Siddappa, 2007, Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering, J Orthop Res, 25, 1029, 10.1002/jor.20402 Haynesworth, 1992, Characterization of cells with osteogenic potential from human marrow, Bone, 13, 81, 10.1016/8756-3282(92)90364-3 Martin, 1997, Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow, Endocrinology, 138, 4456, 10.1210/endo.138.10.5425 Matsushima, 2009, In vivo osteogenic capability of human mesenchymal cells cultured on hydroxyapatite and on beta-tricalcium phosphate, Artif Organs, 33, 474, 10.1111/j.1525-1594.2009.00749.x Barradas, 2013, Molecular mechanisms of biomaterial-driven osteogenic differentiation in human mesenchymal stromal cells, Integr Biol (Camb), 5, 920, 10.1039/c3ib40027a Chai, 2012, Mechanisms of ectopic bone formation by human osteoprogenitor cells on CaP biomaterial carriers, Biomaterials, 33, 3127, 10.1016/j.biomaterials.2012.01.015 Wang, 2014, Effect of phase composition on protein adsorption and osteoinduction of porous calcium phosphate ceramics in mice, J Biomed Mater Res A, 102, 4234 Tang, 2015, Bone morphogenetic protein Smads signaling in mesenchymal stem cells affected by osteoinductive calcium phosphate ceramics, J Biomed Mater Res A, 103, 1001, 10.1002/jbm.a.35242 Sun, 2015, Calcium phosphate scaffolds combined with bone morphogenetic proteins or mesenchymal stem cells in bone tissue engineering, Chin Med J (Engl), 128, 1121, 10.4103/0366-6999.155121 Chen, 2012, Umbilical cord stem cells released from alginate-fibrin microbeads inside macroporous and biofunctionalized calcium phosphate cement fir bone regeneration, Acta Biomater, 8, 2297, 10.1016/j.actbio.2012.02.021 Gibson, 1982, The mechanics of 3-dimensional cellular materials, Proc Royal Soc Lond Ser A—Math Phys Eng Sci, 382, 43, 10.1098/rspa.1982.0088 Mullens, 2005, Characterization of structure and morphology, Cell Ceram Struct Manuf Prop Appl, 227 Gibson, 1999 1977, 919 Cancedda, 2007, Bulk and interface investigations of scaffolds and tissue-engineered bones by X-ray microtomography and X-ray microdiffraction, Biomaterials, 28, 2505, 10.1016/j.biomaterials.2007.01.022 Hildebrand, 1996, Structure model index: a new method to describe remodeling of trabecular bone, Bone (New York), 19, 143S Hildebrand, 1997, A new method for the model-independent assessment of thickness in three-dimensional images, J Microsc—Oxford, 185, 67, 10.1046/j.1365-2818.1997.1340694.x ASTM, 2011, F2883-11 standard guide for characterization of ceramic and mineral based scaffolds used for Tissue-Engineered Medical Products (TEMPs) and as device for surgical implant applications ASTM, 2015 ASTM, 2010 ASTM, 2014, F2721-09 standard guide for pre-clinical in vivo evaluation in critical size segmental bone defects—developed by subcommittee: F04.44 ASTM, 2012, F2884-12 standard Guide for pre-clinical in vivo evaluation of spinal fusion ASTM, 2013, F2529-13 standard guide for in vivo evaluation of osteoinductive potential for materials containing demineralized bone (DBM) Kokubo, 1991, Bioactive glass ceramics: properties and applications, Biomaterials, 12, 155, 10.1016/0142-9612(91)90194-F Boskey, 2008, Cell culture systems for studies of bone and tooth mineralization, Chem Rev, 108, 4716, 10.1021/cr0782473 Walmsley, 2015, High-throughput screening of surface marker expression on undifferentiated and differentiated human adipose-derived stromal cells, Tissue Eng Part A, 21, 2281, 10.1089/ten.tea.2015.0039 Zadpoor, 2014, Relationship between in vitro apatite-forming ability measured using simulated body fluid and in vivo bioactivity of biomaterials, Mater Sci Eng C Mater Biol Appl, 35, 134, 10.1016/j.msec.2013.10.026 ASTM, 2014, F3106-14 standard guide for in vitro osteoblast differentiation assays—developed by subcommittee: F04.43 ASTM, 2013, F2997-13 standard practice for quantification of calcium deposits in osteogenic culture of progenitor cells using fluorescent image analysis—developed by subcommittee: F04.43 Cassiede, 1996, Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro, J Bone Miner Res, 11, 1264, 10.1002/jbmr.5650110911 Kuhn, 2010, A nondestructive method for evaluating in vitro osteoblast differentiation on biomaterials using osteoblast-specific fluorescence, Tissue Eng Part C Methods, 16, 1357, 10.1089/ten.tec.2009.0701 Markovic, 2004, Preparation and comprehensive characterization of a calcium hydroxyapatite reference material, J Res Natl Inst Stand Technol, 109, 553, 10.6028/jres.109.042 Gibson, 1999, Chemical characterization of silicon-substituted hydroxyapatite, J Biomed Mater Res, 44, 422, 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-# Ergun, 2002, Hydroxylapatite with substituted magnesium, zinc, cadmium, and yttrium. I. Structure and microstructure, J Biomed Mater Res, 59, 305, 10.1002/jbm.1246 Sudarsanan, 1972, Structure of strontium hydroxide phosphate, Sr5(PO4)3OH, Acta Cryst, B28, 3668, 10.1107/S0567740872008544